PHARMACEUTICAL DRUGS NATURE

Brand Owner (click to sort) Address Description
CALLIDITAS Calliditas Therapeutics AB PO Box 70351 Stockholm SE-10724 Sweden Pharmaceutical drugs in the nature of preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of Berger's disease; pharmaceutical preparations for the treatment of asthma, bowel diseases, and allergies; pharmaceutical preparations for the treatment of liver diseases and immune system diseases;
CALLIDITAS THERAPEUTICS Calliditas Therapeutics AB PO Box 70351 Stockholm SE-10724 Sweden Pharmaceutical drugs in the nature of preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of Berger's disease; pharmaceutical preparations for the treatment of bowel diseases, and pharmaceutical preparations for the treatment of liver diseases and immune system diseases;THERAPEUTICS;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention concerns novel derivatives of 3,3-diphenylpropylamines, methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for preparing drugs. More particularly, the invention relates to novel prodrugs of antimuscarinic agents with superior pharmacokinetic properties compared to existing drugs such as oxybutynin and tolterodine, methods for their preparation, pharmaceutical compositions containing them, a method of using said compounds and compositions for the treatment of urinary incontinence, gastrointestinal hyperactivity (irritable bowel syndrome) and other smooth muscle contractile conditions.